These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 33080685)

  • 21. Omeprazole-induced Visual Hallucinations: A Case Report.
    Kim GS; Nunez T; Vargas E
    J Psychiatr Pract; 2021 Sep; 27(5):400-403. PubMed ID: 34529608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration.
    Maximova N; Maestro A; Zanon D; Marcuzzi A
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32066648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypersensitivity reactions to proton-pump inhibitors: Clinical presentation, diagnosis, and management.
    Kepil Özdemir S; Bavbek S
    Allergy Asthma Proc; 2020 Mar; 41(2):e37-e44. PubMed ID: 32122452
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypersensitivity reactions to proton pump inhibitors.
    Chang YS
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):348-53. PubMed ID: 22744268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DRESS syndrome in the setting of oxacillin therapy-a call for better patient preparedness: a case report.
    Abu HO; Ali SMJ; Phuyal A; Sherif A; Williams GT; Chastain I
    J Med Case Rep; 2021 Dec; 15(1):613. PubMed ID: 34955100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia.
    Gómez-Torrijos E; García-Rodríguez R; Castro-Jiménez A; Rodríguez-Sanchez J; Méndez Díaz Y; Molina-Infante J
    Aliment Pharmacol Ther; 2016 Feb; 43(4):534-40. PubMed ID: 26662868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton pump inhibitors and acute interstitial nephritis.
    Geevasinga N; Coleman PL; Webster AC; Roger SD
    Clin Gastroenterol Hepatol; 2006 May; 4(5):597-604. PubMed ID: 16630752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxic epidermal necrolysis and neutropaenia: complications of omeprazole.
    Thakor AS; Burke A; Handfield-Jones S; Sinha A; Palmer M; Burns A
    Australas J Dermatol; 2009 Aug; 50(3):207-10. PubMed ID: 19659985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
    Sharpe A; Mourad BM; Hardwick CJ; Reilly T; Dweck E; Bondarsky E
    Am J Case Rep; 2019 Mar; 20():345-348. PubMed ID: 30877266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When fever is more than infection: two cases of vancomycin-induced drug reaction with eosinophilia and systemic symptoms (DRESS).
    Cox M; Paviour S; Gregory S; Chew R
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33414117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactivation of Human Herpes Virus-6 in the Renal Tissue of a Patient with Drug-induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
    Hagiya H; Iwamuro M; Tanaka T; Hasegawa K; Hanayama Y; Kimura M; Otsuka F
    Intern Med; 2016; 55(13):1769-74. PubMed ID: 27374681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.
    dos Santos LM; Guerra RA; Lazaretti-Castro M; Vieira JG; Portes Ede S; Dias-da-Silva MR
    Magnes Res; 2015 Dec; 28(4):136-45. PubMed ID: 26878253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulomatous tubulointerstitial nephritis secondary to omeprazole.
    Nadri Q; Althaf MM
    BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25323274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPIs and kidney disease: from AIN to CKD.
    Moledina DG; Perazella MA
    J Nephrol; 2016 Oct; 29(5):611-6. PubMed ID: 27072818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent safety concerns with proton pump inhibitors.
    Chen J; Yuan YC; Leontiadis GI; Howden CW
    J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fever, eosinophilia, and death: a case of minocycline hypersensitivity.
    Wu PA; Anadkat MJ
    Cutis; 2014 Feb; 93(2):107-10. PubMed ID: 24605348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases.
    Simpson IJ; Marshall MR; Pilmore H; Manley P; Williams L; Thein H; Voss D
    Nephrology (Carlton); 2006 Oct; 11(5):381-5. PubMed ID: 17014549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after β-lactams intake: a diagnostic challenge.
    Dondi A; Parladori R; Mori F; Liccioli G; Bassi A; Lanari M; Patrizi A; Neri I
    Eur J Pediatr; 2021 Jul; 180(7):2327-2332. PubMed ID: 33686529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug reaction with eosinophilia and systemic symptoms syndrome in a patient taking lamotrigine.
    Lameiras C; Ornelas É; Mendes Lopes M; Dória MDC
    BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31653619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome and hepatitis induced by phenytoin.
    Velasco MJ; McDermott J
    Int J Dermatol; 2014 Apr; 53(4):490-3. PubMed ID: 23829691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.